These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 25377913)

  • 1. The discovery of hypertension: evolving views on the role of the kidneys, and current hot topics.
    Johnson RJ; Lanaspa MA; Gabriela Sánchez-Lozada L; Rodriguez-Iturbe B
    Am J Physiol Renal Physiol; 2015 Feb; 308(3):F167-78. PubMed ID: 25377913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The kidney, hypertension, and obesity.
    Hall JE
    Hypertension; 2003 Mar; 41(3 Pt 2):625-33. PubMed ID: 12623970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathogenesis of essential hypertension: historical paradigms and modern insights.
    Johnson RJ; Feig DI; Nakagawa T; Sanchez-Lozada LG; Rodriguez-Iturbe B
    J Hypertens; 2008 Mar; 26(3):381-91. PubMed ID: 18300843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Salt-Sensitive Hypertension: Perspectives on Intrarenal Mechanisms.
    Majid DS; Prieto MC; Navar LG
    Curr Hypertens Rev; 2015; 11(1):38-48. PubMed ID: 26028244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term low salt diet increases blood pressure by activation of the renin-angiotensin and sympathetic nervous systems.
    Wang J; Deng Y; Zou X; Luo H; Jose PA; Fu C; Yang J; Zeng C
    Clin Exp Hypertens; 2019; 41(8):739-746. PubMed ID: 30451012
    [No Abstract]   [Full Text] [Related]  

  • 6. Is obesity a major cause of chronic kidney disease?
    Hall JE; Henegar JR; Dwyer TM; Liu J; Da Silva AA; Kuo JJ; Tallam L
    Adv Ren Replace Ther; 2004 Jan; 11(1):41-54. PubMed ID: 14730537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathophysiology of salt-sensitive hypertension: a new scope of an old problem.
    Franco M; Sanchez-Lozada LG; Bautista R; Johnson RJ; Rodriguez-Iturbe B
    Blood Purif; 2008; 26(1):45-8. PubMed ID: 18182795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Salt Intake on the Pathogenesis and Treatment of Hypertension.
    Rust P; Ekmekcioglu C
    Adv Exp Med Biol; 2017; 956():61-84. PubMed ID: 27757935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathophysiology of obesity hypertension.
    Hall JE
    Curr Hypertens Rep; 2000 Apr; 2(2):139-47. PubMed ID: 10981140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal arteriolar injury by salt intake contributes to salt memory for the development of hypertension.
    Oguchi H; Sasamura H; Shinoda K; Morita S; Kono H; Nakagawa K; Ishiguro K; Hayashi K; Nakamura M; Azegami T; Oya M; Itoh H
    Hypertension; 2014 Oct; 64(4):784-91. PubMed ID: 24980670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular Mechanisms of Sodium-Sensitive Hypertension in the Metabolic Syndrome.
    Nizar JM; Bhalla V
    Curr Hypertens Rep; 2017 Aug; 19(8):60. PubMed ID: 28676941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of hypertension and kidney disease in obesity.
    Hall JE; Brands MW; Henegar JR
    Ann N Y Acad Sci; 1999 Nov; 892():91-107. PubMed ID: 10842655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypothesis: the role of acquired tubulointerstitial disease in the pathogenesis of salt-dependent hypertension.
    Johnson RJ; Schreiner GF
    Kidney Int; 1997 Nov; 52(5):1169-79. PubMed ID: 9350640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The renin-angiotensin system: renal actions and blood pressure regulation.
    Hall JE
    Compr Ther; 1991 May; 17(5):8-17. PubMed ID: 1879129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypertension in Chronic Kidney Disease.
    Hamrahian SM; Falkner B
    Adv Exp Med Biol; 2017; 956():307-325. PubMed ID: 27873228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal function in one-kidney, one-clip hypertension and low renin essential hypertension.
    Hall JE
    Am J Hypertens; 1991 Oct; 4(10 Pt 2):523S-533S. PubMed ID: 1741989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comments on Point:Counterpoint: The dominant contributor to systemic hypertension: Chronic activation of the sympathetic nervous system vs. Activation of the intrarenal renin-angiotensin system. Obesity: a common prime mover of chronic activation of the sympathetic nervous system and the renin-angiotensin system in systemic hypertension?
    Szelényi Z
    J Appl Physiol (1985); 2010 Dec; 109(6):2008-9. PubMed ID: 21188835
    [No Abstract]   [Full Text] [Related]  

  • 18. Plasma sodium: ignored and underestimated.
    He FJ; Markandu ND; Sagnella GA; de Wardener HE; MacGregor GA
    Hypertension; 2005 Jan; 45(1):98-102. PubMed ID: 15557392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypertension Associated with Fructose and High Salt: Renal and Sympathetic Mechanisms.
    Komnenov D; Levanovich PE; Rossi NF
    Nutrients; 2019 Mar; 11(3):. PubMed ID: 30866441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tempol or candesartan prevents high-fat diet-induced hypertension and renal damage in spontaneously hypertensive rats.
    Chung S; Park CW; Shin SJ; Lim JH; Chung HW; Youn DY; Kim HW; Kim BS; Lee JH; Kim GH; Chang YS
    Nephrol Dial Transplant; 2010 Feb; 25(2):389-99. PubMed ID: 19749146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.